The Patent Finder

Byondis B.V.

Also on record
Records under this name other than the patents Byondis B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.

Showing 1 to 9 of 9 · Back to Byondis B.V.

PatentTitleStatus Expires Confidence
US 10,092,659Duocarmycin Adcs for Use in Treatment of Endometrial Cancer
Lapsed on the fee record
Ended Oct 9, 2026 · High confidence
Lapsed on the fee recordEnded Oct 9, 2026High confidence
US 11,382,982Duocarmycin Adcs Showing Improved in Vivo Antitumor Activity
Lapsed on the fee record
Ended Jul 12, 2026 · High confidence
Lapsed on the fee recordEnded Jul 12, 2026High confidence
US 11,008,400Anti-5T4 antibodies and antibody-drug conjugates
Lapsed on the fee record
Ended May 18, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 18, 2025From the USPTO record
US 9,629,924Conjugates of CC-1065 analogs and bifunctional linkers
Lapsed on the fee record
Ended Apr 25, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 25, 2025From the USPTO record
US 9,580,501Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseases
Lapsed on the fee record
Ended Feb 28, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 28, 2025From the USPTO record
US 9,573,996Monoclonal antibodies to human proinflammatory cytokines and methods for treating inflammatory diseases
Lapsed on the fee record
Ended Feb 21, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 21, 2025From the USPTO record
US 10,821,191SYD985 treatment of T-DM1 refractory cancer patients
Lapsed on the fee record
Ended Nov 3, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 3, 2024From the USPTO record
US 8,158,590Triazole-containing releasable linkers, conjugates thereof, and methods of preparation
Lapsed on the fee record
Ended Apr 17, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 17, 2024From the USPTO record
US 7,223,837Elongated and multiple spacers in activatible prodrugs
Term ended
Term ended Mar 25, 2022 · From the USPTO record
Term endedTerm ended Mar 25, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited